AstraZeneca, Gatehouse Bio extend partnership to develop RNA therapeutics for heart failure
US-based small RNA therapeutics company Gatehouse Bio and British biopharmaceutical company AstraZeneca are extending their existing collaboration to develop RNA therapeutics for heart failure. In December 2019, the